结直肠癌个体化治疗的研究进展

被引:2
作者
李进
何敬东
机构
[1] 南京医科大学附属淮安医院肿瘤内科
关键词
结直肠癌; 个体化治疗; 分子标志;
D O I
10.16352/j.issn.1001-6325.2010.01.027
中图分类号
R735.34 [];
学科分类号
摘要
化疗在晚期大肠癌的治疗中具有重要地位。不同化疗药物的选择影响疗效和预后。以药物基因组学为基础的大肠癌个体化治疗开始得到重视,本文就分子标记对大肠癌化疗药物包括氟脲嘧啶类、奥沙利铂、伊立替康及分子靶向药物疗效影响的研究现状进行综述,探讨大肠癌个体化治疗发展。
引用
收藏
页码:97 / 99
页数:3
相关论文
共 7 条
[1]
Hedgehog Pathway Inhibitor HhAntag691 Is a Potent Inhibitor of ABCG2/BCRP and ABCB1/Pgp [J].
Zhang, Yimao ;
Laterra, John ;
Pomper, Martin G. .
NEOPLASIA, 2009, 11 (01) :96-101
[2]
Setting future standards for KRAS testing in colorectal cancer [J].
van Krieken, H. ;
Tol, J. .
PHARMACOGENOMICS, 2009, 10 (01) :1-3
[3]
Pharmacogenetic relevance of MTHFR polymorphisms.[J].Giuseppe Toffoli;Elena De Mattia.Pharmacogenomics.2008, 9
[4]
Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors [J].
Lin, Chia-Chi ;
Calvo, Emiliano ;
Papadopoulos, Kyriakos P. ;
Patnaik, Amita ;
Sarantopoulos, John ;
Mita, Alain C. ;
Preston, Glenn G. ;
Mita, Monica M. ;
Rodon, Jordi ;
Mays, Theresa ;
Yeh, I-Tien ;
O'Rourke, Pat ;
Takimoto, Chris H. ;
Dancey, Janet E. ;
Chen, Helen ;
Tolcher, Anthony W. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (06) :1065-1071
[5]
UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients [J].
Onoue, Masahide ;
Terada, Tomohiro ;
Kobayashi, Masahiko ;
Katsura, Toshiya ;
Matsumoto, Shigemi ;
Yanagihara, Kazuhiro ;
Nishimura, Takafumi ;
Kanai, Masashi ;
Teramukai, Satoshi ;
Shimizu, Akira ;
Fukushima, Masanori ;
Inui, Ken-ichi .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (02) :136-142
[6]
Glutathione-S-transferase P1, T1 and M1 genetic polymorphisms in neoadjuvant-treated locally advanced gastric cancer:: GSTM1-present genotype is associated with better prognosis in completely resected patients [J].
Ott, Katja ;
Lordick, Florian ;
Becker, Karen ;
Ulm, Kurt ;
Siewert, JoergRuediger ;
Hoefler, Heinz ;
Keller, Gisela .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2008, 23 (08) :773-782
[7]
G>C SNP of thymidylate synthase with respect to colorectal cancer.[J].Milena Gusella;Roberto Padrini.Pharmacogenomics.2007, 8